These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25119170)

  • 1. Selected immunohistochemical features of conventional renal cell carcinomas coexpressing P53 and MDM2.
    Hejnold M; Dyduch G; Białas M; Demczuk S; Ryś J; Chłosta P; Szopiński T; Okoń K
    Pol J Pathol; 2014 Jun; 65(2):113-9. PubMed ID: 25119170
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selected morphologic features influencing the prognosis of conventional renal cell carcinomas co-expressing P53 and MDM2.
    Hejnold M; Dyduch G; Białas M; Demczuk S; Ryś J; Szopiński T; Chłosta P; Okoń K
    Pol J Pathol; 2014 Mar; 65(1):29-33. PubMed ID: 25119006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of p53, mdm2, and bcl-2 proteins in renal cell carcinoma.
    Uchida T; Gao JP; Wang C; Jiang SX; Muramoto M; Satoh T; Minei S; Shimura S; Irie A; Kameya T; Baba S
    Urology; 2002 Apr; 59(4):615-20. PubMed ID: 11927338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. P53 and MDM2 Over-expression and Five-year Survival of Kidney Cancer Patients Undergoing Radical Nephrectomy--Iranian Experience.
    Abolhasani M; Salarinejad S; Asgari M
    Asian Pac J Cancer Prev; 2015; 16(12):5043-7. PubMed ID: 26163638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of CD44 and P53 in renal cell carcinoma: association with tumor subtypes.
    Noroozinia F; Fahmideh AN; Yekta Z; Rouhrazi H; Rasmi Y
    Saudi J Kidney Dis Transpl; 2014 Jan; 25(1):79-84. PubMed ID: 24434386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter.
    Hashimoto H; Sue Y; Saga Y; Tokumitsu M; Yachiku S
    Int J Urol; 2000 Dec; 7(12):457-63. PubMed ID: 11168685
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of p53, MDM2 and c-erb B-2 oncoproteins, epidermal growth factor receptor and proliferation markers in the prognosis of urinary bladder cancer.
    Korkolopoulou P; Christodoulou P; Kapralos P; Exarchakos M; Bisbiroula A; Hadjiyannakis M; Georgountzos C; Thomas-Tsagli E
    Pathol Res Pract; 1997; 193(11-12):767-75. PubMed ID: 9521509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Value of immunohistochemical Ki-67 and p53 determinations as predictive factors of outcome in renal cell carcinoma.
    Rioux-Leclercq N; Turlin B; Bansard J; Patard J; Manunta A; Moulinoux JP; Guillé F; Ramée MP; Lobel B
    Urology; 2000 Apr; 55(4):501-5. PubMed ID: 10736491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
    Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
    Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor.
    Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E
    Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deregulation of p53-MDM2 auto-regulatory pathway in breast carcinoma.
    Baliou E; Nonni A; Keramopoulos D; Ragos V; Tsiambas E; Patsouris E; Pavlakis K
    J BUON; 2016; 21(5):1099-1103. PubMed ID: 27837610
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 expression in correlation to clinical outcome in patients with renal cell carcinoma.
    Ljungberg B; Bozoky B; Kovacs G; Stattin P; Farrelly E; Nylander K; Landberg G
    Scand J Urol Nephrol; 2001 Feb; 35(1):15-20. PubMed ID: 11291681
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mdm2 expression as a prognostic indicator in clear cell renal cell carcinoma: comparison with p53 overexpression and clinicopathological parameters.
    Haitel A; Wiener HG; Baethge U; Marberger M; Susani M
    Clin Cancer Res; 2000 May; 6(5):1840-4. PubMed ID: 10815906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biologic behavior of and p53 overexpression in multifocal renal cell carcinoma of clear cell type: an immunohistochemical study correlating grading, staging, and proliferation markers.
    Haitel A; Wiener HG; Blaschitz U; Marberger M; Susani M
    Cancer; 1999 Apr; 85(7):1593-8. PubMed ID: 10193951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined p53 and MDM2 biomarker analysis shows a unique pattern of expression associated with poor prognosis in patients with renal cell carcinoma undergoing radical nephrectomy.
    Noon AP; Polański R; El-Fert AY; Kalirai H; Shawki H; Campbell F; Dodson A; Eccles RM; Lloyd BH; Sibson DR; Coupland SE; Lake SL; Parsons K; Vlatković N; Boyd MT
    BJU Int; 2012 Apr; 109(8):1250-7. PubMed ID: 21756282
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictive value of cell cycle markers p53, MDM2, p21, and Ki-67 in superficial bladder tumor recurrence.
    Pfister C; Moore L; Allard P; Larue H; Lacombe L; Têtu B; Meyer F; Fradet Y
    Clin Cancer Res; 1999 Dec; 5(12):4079-84. PubMed ID: 10632343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determination of stage in nonmuscle urothelial carcinoma: Staining pattern of caspase-8.
    Türk NŞ; Eskiçorapçi S; Aybek Z; Tuncay L
    Indian J Pathol Microbiol; 2018; 61(2):192-196. PubMed ID: 29676355
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of murine double minute 2 is a favorable prognostic marker in esophageal squamous cell carcinoma without p53 protein accumulation.
    Saito H; Tsujitani S; Oka S; Ikeguchi M; Maeta M; Kaibara N
    Ann Surg Oncol; 2002 Jun; 9(5):450-6. PubMed ID: 12052755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical status of p53, mdm2 and Ki-67 in malignant fibrous histiocytoma.
    Szadowska A; Olborski B; Harezga-Bal B; Debiec-Rychter M
    Pol J Pathol; 1998; 49(1):15-21. PubMed ID: 9640970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.